This persistent IFNγ activity is associated with an altered melanoma secretome and favored an immune-suppressive environment enriched for exhausted CD8+ T cells and elevated expression of immune inhibitory ligands PD-L1, PD-L2, and galectin 9. The gene discussed is LGALS9; the disease is melanoma.